Aegon N.V. (AEG) |
|
4.57 -0.01 (-0.22%)
|
11-19 16:03 |
|
Open: |
4.61 |
Pre. Close: |
4.58 |
|
High:
|
4.62 |
Low:
|
4.56 |
|
Volume:
|
899,578 |
Market Cap:
|
9243M |
|
|
|
|
Aegon NV is engaged in providing life insurance, pensions and asset management products and services in the USA, Europe, and Asia. It offers life and protection, and accidental death products as well as individual savings and retirement products. |
Stock Price Prediction |
Update at 5:00pm EST |
|
If tomorrow:
|
Open lower
|
Open higher
|
|
High:
|
4.622 - 4.653 |
4.653 - 4.679 |
|
Low:
|
4.5 - 4.53 |
4.53 - 4.556 |
|
Close:
|
4.525 - 4.575 |
4.575 - 4.616 |
|
Technical analysis |
as of: 2019-11-19 4:24:01 PM |
|
Overall:
|
 |
| Stoxline posted a SELL today, same as yesterday. Downward movement continues. |
| Target: |
Six months: 5.48 One year: 6.40 |
| Support: |
Support1: 4.41  Support2: 4.24 |
| Resistance: |
Resistance1: 4.69 Resistance2: 5.48 |
| Pivot: |
4.55 |
| Moving Average: |
MA(5): 4.58  MA(20): 4.52
MA(100): 4.40 MA(250): 4.76 |
| MACD: |
MACD(12,26): 0.09 Signal(9): 0.10 |
| Stochastic oscillator: |
%K(14,3): 76.02 %D(3): 75.47 |
| RSI: |
RSI(14): 59.89 |
| 52-week: |
High: 5.72 Low: 3.69 Change(%): -19.5 |
| Average Vol(K): |
3-Month: 159687 10-Days: 144871 |
|
Price, moving averages and Bollinger Bands |
|
Price and moving averages has closed above its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BULLISH in short-term; and NEUTRAL in mid-long term.AEG has closed below upper band by 43.2%. Bollinger Bands are 28.7% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices. |
|
|
Headline News |
2019-11-14
Allergan, Exicure Strike Collaboration Agreement For Hair Loss Disorder Drugs
Shares of the thinly traded micro-cap Exicure Inc (NASDAQ: XCUR ) were advancing strongly Thursday in the wake of a collaboration agreement announced by the company with Allergan plc (NYSE: AGN ). Exicure Receives $25M Upfront Exicure — a biotech company developing therapies for immuno-oncology, inflammatory diseases and genetic disorders — said the collaboration agreement pertains to discovery and development of novel treatments for hair loss disorders based on its proprietary SNA technology. The agreement provides for Allergan receiving exclusive access and options to license SNA-based therapeutics arising from two collaboration programs by making an upfront payment of $25 million to Exicure. The latter will conduct discovery and development in the two programs for hair loss disorders. If Allergan exercises an … Full story available on Benzinga.com
2019-11-13
The Daily Biotech Pulse: Merck Goes Shopping, Nuvectra Files For Bankruptcy Protection, Opiant Rips Higher
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting 52-week highs on Nov. 12) ACADIA Pharmaceuticals Inc (NASDAQ: ACAD ) Allergan plc (NYSE: AGN ) Amgen, Inc. (NASDAQ: AMGN ) Antares Pharma Inc (NASDAQ: ATRS ) Arrowhead Pharmaceuticals Inc (NASDAQ: ARWR ) Bio-Rad Laboratories, Inc. Class A Common Stock (NYSE: BIO ) Bristol-Myers Squibb Co (NYSE: BMY ) Celgene Corporation (NASDAQ: CELG ) Crispr Therapeutics AG (NASDAQ: CRSP ) Diplomat Pharmacy Inc (NYSE: DPLO )( warned of going concern risk) Dicerna Pharmaceuticals Inc (NASDAQ: DRNA ) DexCom, Inc. (NASDAQ: DXCM ) GALAPAGOS NV/S ADR (NASDAQ: GLPG ) Galera Therapeutics Inc (NASDAQ: GRTX ) Insulet Corporation (NASDAQ: PODD ) Karyopharm Therapeutics Inc (NASDAQ: KPTI ) Momenta Pharmaceuticals, Inc. (NASDAQ: MNTA ) Neurocrine Biosciences, Inc. (NASDAQ: NBIX ) Seattle Genetics, Inc. (NASDAQ: SGEN ) Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX ) X T L Biopharmaceuticals Ltd (NASDAQ: XTLB ) XOMA Corp (NASDAQ: XOMA ) Zai Lab Ltd (NASDAQ: ZLAB ) Zimmer Biomet Holdings Inc (NYSE: ZBH ) Down In The Dumps (Biotech stocks hitting 52-week lows on Nov.
|
Financial Analysis |
| Growth |
 |
| Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing. |
| Profitability |
 |
| Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs. |
| Solvency |
 |
| Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry. |
| Efficiency |
|
| Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not. |
| Click here to get more fundamental analysis.
|
|
|
|
|
|
|
| Free Technical Analysis Charts
|
|
|
Stock Basics & Statistics |
| Exchange: New York Stock Exchange |
| Sector: Financial Services |
| Industry: Insurance - Diversified |
| Shares Out. (M) |
2010.00 |
| Shares Float (M) |
1750.00 |
|
% Held by Insiders
|
|
|
% Held by Institutions
|
8.11 |
|
Shares Short (K)
|
2710 |
|
Shares Short P. Month (K)
|
|
Stock Financials |
|
EPS
|
1.092 |
|
Book Value (p.s.)
|
13.540 |
|
PEG Ratio
|
|
|
Profit Margin
|
1.28 |
|
Operating Margin
|
|
|
Return on Assets (ttm)
|
0.1 |
|
Return on Equity (ttm)
|
2.2 |
|
Qtrly Rev. Growth
|
132.7 |
|
Gross Profit (p.s.)
|
2.333 |
|
Sales Per Share
|
|
|
EBITDA (p.s.)
|
|
|
Qtrly Earnings Growth
|
-38.10 |
|
Operating Cash Flow (M)
|
|
|
Levered Free Cash Flow (M)
|
|
Stock Valuations |
|
P/E
|
4.19 |
|
P/E Growth Ratio
|
|
|
P/BV
|
0.34 |
|
P/S
|
|
|
P/CF
|
|
Dividends & Splits |
|
Dividend
|
0.330 |
|
Dividend Yield
|
0.07 |
|
Dividend Pay Date
|
2019-09-20 |
|
Ex-Dividend Date
|
2019-08-23 |
|
Forward Dividend
|
0.330 |
|
Last Split Date
|
|
|
Last Split Ratio
|
-1e+010 |
|
7 Binary Options
|
|
Your Ad Here
|
|
